# MICROBOT                                             MEDICAL INC. (MBOT) · Edgar & Edgarette company card

> Microbot                                             Medical (MBOT) saw revenue fall 88.5% in FY2015 to $0 million, operating margin 783% against a 1.2% median for surgical & medical instruments & apparatus, equity -12.1% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 883975 · fiscal year ended 2015-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/MBOT) · [JSON](https://www.pops4.com/boards/company/MBOT.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $116,887 |
| Revenue growth, 1 year | -88.5% |
| Revenue growth per year | -44.4% |
| Operating margin | 782.8% (prior year -3053.2%) |
| Net margin | -787.9% |
| Operating cash flow | −$765,000 |
| Capital spending | $2,000 |
| Free cash flow | −$767,000 |
| Cash | $437,000 |
| Long-term debt | — |
| Total assets | $529,000 |
| Total equity | −$64,000 |
| Equity ÷ assets | -12.1% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -5.39 (distress zone)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative (-$13.0M in FY2025); revenue is hard to predict: its 80% range is ±50%

## Edgarette's reading

Exposure: revenue $117K (FY2015). Experience: revenue down 88.5% on the year, down 44.4% a year over 4 years; operating margin 782.8%, up from -3053.2%. Soundness: equity -12.1% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $18K and $56K next year (method v4.1: its own 3-year record of growth weighed at 40% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $17K to $60K. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin 782.8% against a 1.2% median; growth -88.5% against 11.6%.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-08-07 ([filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226036600/0001493152-26-036600-index.htm))

## Recent filings

- DEF 14A · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226049715/0001493152-26-049715-index.htm)
- 8-K · filed 2026-10-27 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226048640/0001493152-26-048640-index.htm)
- 8-K · filed 2026-10-23 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226048182/0001493152-26-048182-index.htm)
- 8-K · filed 2026-10-20 · 5.08 Shareholder Nominations Pursuant to Rule 14a-11; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226047702/0001493152-26-047702-index.htm)
- 8-K · filed 2026-10-06 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226045866/0001493152-26-045866-index.htm)
- 8-K · filed 2026-09-28 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883975/000149315226044429/0001493152-26-044429-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000883975.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=883975

## Cite

POPS4, Edgar & Edgarette: MICROBOT                                             MEDICAL INC. (MBOT) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/MBOT. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Its latest audited year is FY2025, which reports no revenue; the revenue figures and the range here are from FY2015, its last year with revenue on record. Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.